Clover Health Investments, Corp. Q3 2025 Earnings Recap

CLOV Q3 2025 November 6, 2025

Get alerts when CLOV reports next quarter

Clover Health's Q3 2025 results reflect strong membership growth of 35% and revenue increase of nearly 50% year-over-year, but adjusted EBITDA profitability fell short due to higher than expected new member acquisition costs.

Earnings Per Share Miss

$-0.05 vs $0.02 est.

-350.0% surprise

Revenue Beat

496650000 vs 467055910 est.

+6.3% surprise

Market Reaction

1-Day -11.97%

5-Day -14.0%

30-Day -15.68%

See CLOV alongside your other holdings

Add to your portfolio — free

Key Takeaways

Sustained profitable growth despite missing adjusted EBITDA targets, attributed to increased new member dilution.
Continued strong performance of Clover Assistant, leading to top HEDIS clinical quality scores in the PPO segment.
Full-year outlook revised to expect 44,000 new members, with profitability projected to improve significantly in 2026.
Focused refocus on managing new member utilization through enhanced Clover Assistant engagement.
Strong retention rates expected to drive returning member profitability and support long-term growth strategy.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit CLOV on AllInvestView.

Next Q1 2026